Literature DB >> 3215190

Effect of imaging time on the values of the sacroiliac index.

D Dodig1, Z Domljan, S Popović, I Simonović.   

Abstract

Quantitative scintigraphy of the sacroiliac joints was performed in a group of normal subjects and a group of subjects with unilateral and bilateral sacroiliitis. The aim of the study was to determine whether the time intervals of imaging had any effect on the values of the sacroiliac index. Imaging was performed every 30 min up to 300 min and the indices were calculated at the time intervals mentioned. We found that the values of the sacroiliac index increased in the group of normal subjects until 150 min after the application of the radiopharmaceutical, and that in the group of subjects who had sacroiliitis they increased until 210 min. The results show that the time interval optimal to quantitative sacroiliac joint imaging is at least 3 1/2 h after administration of the radiopharmaceutical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215190     DOI: 10.1007/bf00252397

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Investigation of sacroiliac disease: Comparative evaluation of radiological and radionuclide techniques.

Authors:  A S Russell; B C Lentle; J S Percy
Journal:  J Rheumatol       Date:  1975-03       Impact factor: 4.666

2.  Nucleographic studies of axial spondarthritides. I. Quantitative sacroiliac scintigraphy in early HLA-B27-associated sacroiliitis.

Authors:  T C Namey; J McIntyre; M Buse; E C LeRoy
Journal:  Arthritis Rheum       Date:  1977-06

3.  Applications and limitations of quantitative sacroiliac joint scintigraphy.

Authors:  R P Goldberg; H K Genant; R Shimshak; D Shames
Journal:  Radiology       Date:  1978-09       Impact factor: 11.105

4.  Influence of age on quantitative sacro-iliac joint imaging.

Authors:  D Dodig; S Popović; Z Domljan
Journal:  Eur J Nucl Med       Date:  1984

5.  Quantitative scintigraphy of sacroiliac joints: effects of age, gender, and laterality.

Authors:  K Vyas; M Eklem; H Seto; V R Bobba; P Brown; J Haines; G T Krishnamurthy
Journal:  AJR Am J Roentgenol       Date:  1981-03       Impact factor: 3.959

6.  The reliability of quantitative bone scanning in sacro-iliitis.

Authors:  B Domeij-Nyberg; M Kjällman; O Nylén; N O Petterson
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

7.  Diagnostic value of sacroiliac joint scintigraphy with 99m technetium pyrophosphate in sacroiliitis.

Authors:  H Berghs; J Remans; L Drieskens; L Kiebooms; J Polderman
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

8.  Scintiscanning in ankylosing spondylitis: a clinical, radiological and quantitative radioisotopic study.

Authors:  D G Spencer; F G Adams; P W Horton; W W Buchanan
Journal:  J Rheumatol       Date:  1979 Jul-Aug       Impact factor: 4.666

9.  Prospective evaluation of sacroiliac scintigraphy in chronic inflammatory back pain.

Authors:  J M Esdaile; L Rosenthall; R Terkeltaub; R Kloiber
Journal:  Arthritis Rheum       Date:  1980-09

10.  Quantitative sacro-iliac scintigraphy. I. Methodological aspects.

Authors:  M Pitkänen; T Lahtinen; S Hyödynmaa; O Mutru; E Länsimies
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

View more
  3 in total

1.  Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up?

Authors:  Mustafa Yildiz; S Ercan Tunc; Mehmet Sahin; Berna Okudan; Osman Aydin; Harun Suslu; Meltem Ozbek
Journal:  Rheumatol Int       Date:  2005-02-03       Impact factor: 2.631

2.  The scintigraphy of sacroiliac joints. A comparison of 99mTc-DPD and 99mTc-MDP.

Authors:  T Lantto
Journal:  Eur J Nucl Med       Date:  1990

3.  Early spondyloarthropathy: scintigraphic, biological, and clinical findings in MRI-positive patients.

Authors:  Orhan Akdeniz; Gamze Alayli; Fevziye Canbaz Tosun; Bariş Diren; Kivanç Cengiz; Mustafa Bekir Selçuk; Tevfik Sünter; Ferhan Cantürk
Journal:  Clin Rheumatol       Date:  2007-09-15       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.